| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Revenue | $64.0M | -5.4% |
| Cost of Revenue | $58.3M | -4.0% |
| Gross Profit | $5.6M | -17.7% |
| R&D Expense | $3.4M | +39.0% |
| SG&A Expense | $22.2M | +20.9% |
| Operating Income | -$20.0M | -43.1% |
| Interest Expense | $5.0M | -2.9% |
| Pre-tax Income | -$22.4M | -21.7% |
| Income Tax | $19K |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $22.6M | -54.5% |
| Accounts Receivable | $15.9M | -22.8% |
| Inventory | $30.2M | +155.0% |
| Current Assets | $74.1M | -14.7% |
| Total Assets | $102.5M | -3.3% |
| Current Liabilities | $103.4M | +200.1% |
| Long-term Debt | $51.0M | +0.0% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$27.5M | -1716.6% |
| Capital Expenditures | $9.9M | +209.3% |
| Investing Cash Flow | -$9.9M | -209.3% |
| Financing Cash Flow | $10.4M | -71.0% |
| Free Cash Flow | -$37.4M | -2381.6% |
| +0.0% |
| Net Income | -$22.4M | -21.7% |
| EPS (Basic) | -$1.52 | +6.7% |
| EPS (Diluted) | -$1.52 | +6.7% |
| Total Liabilities |
| $110.2M |
| +18.7% |
| Stockholders' Equity | -$7.7M | -158.3% |